Article Information
History
- October 1, 2018.
Article Versions
- Version 1 (June 22, 2018 - 13:33).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Sanghee Lim1,
- Nicole Hermance2,
- Tenny Mudianto1,3,
- Hatim M. Mustaly1,
- Ian Paolo Morelos Mauricio1,
- Marc A. Vittoria1,
- Ryan J. Quinton1,
- Brian W. Howell4,
- Hauke Cornils5,
- Amity L. Manning2 and
- Neil J. Ganem1,6,*
- 1The Laboratory of Cancer Cell Biology, Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA
- 2Department of Biology and Biotechnology, Worcester Polytechnic Institute, Worcester, MA
- 3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
- 4Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY
- 5Evotec, Hamburg, Germany
- 6Division of Hematology and Oncology, Department of Medicine, Boston University School of Medicine, Boston, MA
- ↵* Correspondence to: Neil J. Ganem, e-mail: nganem{at}bu.edu Neil J. Ganem The Cancer Center Boston University School of Medicine 72 E. Concord St. K-712C Boston, MA 02118 Phone: (617) 638-5382